Clinical Trial Update: Migraine Survey in Gulf Region

View source ↗

Summary

A clinical trial update indicates that a migraine survey in the Gulf Region sponsored by Novartis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Migraine | Status: TERMINATED